Theravance Biopharma, Inc (TBPH) insider trading
Every open-market stock purchase and sale by Theravance Biopharma, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Rhonda Farnum (VP) and 1 other sold $346K in the last 90 days.
- Last insider buy: Eli Samaha (10% owner), $7.8M, 2 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $3.8M (8 sales). Last close $17.02 on Sep 18, 2026.
Recent TBPH insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 23, 2026 | Weiss Asset Management LP (Insider) | Sold (not open market) | $127M |
| Sep 23, 2026 | Rick E Winningham (CEO) | Sold (not open market) | $5.3M |
| Sep 23, 2026 | Rhonda Farnum (VP) | Sold (not open market) | $3.8M |
| Sep 23, 2026 | Aine Miller (VP) | Sold (not open market) | $953K |
| Sep 23, 2026 | Alsup Laurie Smaldone (Insider) | Sold (not open market) | $380K |
| Sep 23, 2026 | Deepika Pakianathan (Insider) | Sold (not open market) | $351K |
| Sep 23, 2026 | Susannah Gray (Insider) | Sold (not open market) | $322K |
| Sep 23, 2026 | Deepika Pakianathan (Insider) | Sold (not open market) | $284K |
| Sep 23, 2026 | Donal O'Connor (Insider) | Sold (not open market) | $284K |
| Sep 23, 2026 | Alsup Laurie Smaldone (Insider) | Sold (not open market) | $284K |
| Sep 23, 2026 | Dean J Mitchell (Insider) | Sold (not open market) | $284K |
| Sep 23, 2026 | Alsup Laurie Smaldone (Insider) | Sold (not open market) | $241K |
| Sep 23, 2026 | Donal O'Connor (Insider) | Sold (not open market) | $241K |
| Sep 23, 2026 | Deepika Pakianathan (Insider) | Sold (not open market) | $241K |
| Sep 23, 2026 | Dean J Mitchell (Insider) | Sold (not open market) | $241K |
| Sep 23, 2026 | Susannah Gray (Insider) | Sold (not open market) | $241K |
| Sep 23, 2026 | Donal O'Connor (Insider) | Sold (not open market) | $228K |
| Sep 23, 2026 | Deepika Pakianathan (Insider) | Sold (not open market) | $228K |
| Sep 23, 2026 | Alsup Laurie Smaldone (Insider) | Sold (not open market) | $228K |
| Sep 23, 2026 | Susannah Gray (Insider) | Sold (not open market) | $228K |
| Sep 23, 2026 | Dean J Mitchell (Insider) | Sold (not open market) | $228K |
| Sep 23, 2026 | Susannah Gray (Insider) | Sold (not open market) | $224K |
| Sep 23, 2026 | Donal O'Connor (Insider) | Sold (not open market) | $224K |
| Sep 23, 2026 | Alsup Laurie Smaldone (Insider) | Sold (not open market) | $224K |
| Sep 23, 2026 | Dean J Mitchell (Insider) | Sold (not open market) | $224K |
Who's trading TBPH
- Rick E Winningham, CEO: other filings, last Sep 23, 2026
- Rhonda Farnum, VP: sold $1.5M (12 sales), last Sep 23, 2026
- Deepika Pakianathan, Insider: other filings, last Sep 23, 2026
- Aziz Sawaf, CFO: other filings, last Sep 23, 2026
- Alsup Laurie Smaldone, Insider: other filings, last Sep 23, 2026
- Weiss Asset Management LP, Insider: other filings, last Sep 23, 2026
- Susannah Gray, Insider: other filings, last Sep 23, 2026
- Brett A. Grimaud, VP: other filings, last Sep 23, 2026
- Dean J Mitchell, Insider: other filings, last Sep 23, 2026
- Aine Miller, VP: other filings, last Sep 23, 2026
- Donal O'Connor, Insider: other filings, last Sep 23, 2026
- Eli Samaha, 10% owner: sold $119K (2 sales), last Jul 7, 2026
- Eran Broshy, Insider: sold $2.2M (7 sales), last Nov 26, 2025
Get free alerts when an insider at Theravance Biopharma, Inc files a new trade →